Sudarshan Pharma Industries Limited (BOM:543828)

BOM:543828 Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	159.55	114.55	70.37	52.48	26.71
Depreciation & Amortization	10.3	12.29	9.07	8.66	6.24
Other Amortization	2.84	-	-	-	1.19
Other Operating Activities	201.01	96.16	52.66	33	32.63
Change in Accounts Receivable	-365.52	-415.71	-80.33	-130.83	-335.19
Change in Inventory	-526.75	-97.98	-276.98	-229.06	-65.87
Change in Accounts Payable	279.68	-332.55	181.38	295.33	277.81
Change in Other Net Operating Assets	587.95	720.09	-244.11	-67.8	84.38
Operating Cash Flow	349.06	96.86	-287.93	-38.22	27.9
Operating Cash Flow Growth	260.39%	-	-	-	317.81%
Capital Expenditures	-46.93	-37.84	-143.27	-16.56	-13.2
Cash Acquisitions	-0.73	-29.97	-	-	-
Investment in Securities	-164.99	-15	-123.39	-	-
Other Investing Activities	10.23	-8.03	10.14	1.99	0.25
Investing Cash Flow	-202.42	-90.84	-256.52	-14.57	-12.95
Long-Term Debt Issued	-	-	78.49	12.03	12.11
Long-Term Debt Repaid	-0.31	-22.97	-	-	-
Net Debt Issued (Repaid)	-0.31	-22.97	78.49	12.03	12.11
Issuance of Common Stock	-	-	641.61	20.19	-
Common Dividends Paid	-	-7.22	-	-	-
Other Financing Activities	-143.76	-91.63	-60.82	10.38	-27.2
Financing Cash Flow	-144.07	-121.82	659.28	42.61	-15.09
Net Cash Flow	2.57	-115.8	114.83	-10.19	-0.14
Free Cash Flow	302.13	59.02	-431.2	-54.79	14.7
Free Cash Flow Growth	411.94%	-	-	-	-
Free Cash Flow Margin	5.98%	1.27%	-9.35%	-1.53%	0.76%
Free Cash Flow Per Share	1.25	0.25	-1.79	-0.38	0.10
Cash Interest Paid	154.71	90.28	54.02	33.79	32.25
Cash Income Tax Paid	28.41	21.22	21.06	17.68	8.41
Levered Free Cash Flow	-521.19	-731.33	-447.11	-89.26	-98.4
Unlevered Free Cash Flow	-433.03	-682.14	-418.45	-72.02	-80.55
Change in Net Working Capital	639.41	796.9	373.7	127.55	116.43

Source: S&P Global Market Intelligence. Standard template. Financial Sources.